<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<HEAD>
<META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW, NOARCHIVE">
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<title>Janssen-Ortho Inc. v. Amgen Canada Inc. (June 6, 2005)</title>
<style><!--
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	text-align:center;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:15.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-font-kerning:0pt;
	font-weight:normal;}
h2
	{mso-style-next:Normal;
	text-align:center;
	line-height:200%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:15.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-bidi-font-weight:normal;}
h3
	{mso-style-next:Normal;
	text-align:justify;
	mso-pagination:widow-orphan;
	mso-outline-level:3;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-bidi-font-weight:normal;}
h4
	{mso-style-next:Normal;
	text-align:justify;
	line-height:200%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-bidi-font-weight:normal;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{text-align:justify;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{text-align:justify;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;}
p.Doubleindent-quote, li.Doubleindent-quote, div.Doubleindent-quote
	{mso-style-name:"Double indent-quote";
	text-align:justify;
	mso-pagination:widow-orphan;
	tab-stops:1.5in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.headingtitle, li.headingtitle, div.headingtitle
	{mso-style-name:"heading\: title";
	mso-style-update:auto;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in lined 3.0in blank 3.5in 4.5in 5.0in 5.5in 6.5in 7.0in 7.5in 8.5in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.Double-indent-subquote, li.Double-indent-subquote, div.Double-indent-subquote
	{mso-style-name:Double-indent-subquote;
	mso-style-parent:"";
	text-align:justify;
	mso-pagination:none;
	tab-stops:2.0in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.headingNUMBER, li.headingNUMBER, div.headingNUMBER
	{mso-style-name:"heading\: NUMBER";
	mso-style-update:auto;
	text-align:justify;
	text-indent:0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	mso-list:l15 level2 lfo70;
	tab-stops:.5in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.mainparagraphc16, li.mainparagraphc16, div.mainparagraphc16
	{mso-style-name:"mainparagraph c16";
	mso-
	mso-
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Arial Unicode MS";}
span.c20
	{mso-style-name:c20;}
p.ParaNO, li.ParaNO, div.ParaNO
	{mso-style-name:"Para NO \#";
	mso-style-parent:"heading\: NUMBER";
	text-align:justify;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:13.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
span.c21
	{mso-style-name:c21;}
@page Section1
	{size:8.5in 11.0in;
	mso-header-
	mso-footer-
	mso-page-numbers:1;
	mso-title-page:yes;
	mso-even-header: url() eh1;
	mso-header: url() h1;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
@list l0
	{mso-list-id:-132;
	mso-list-type:simple;
	mso-list-template-ids:-1537716272;}
@list l0:level1
	{mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l1
	{mso-list-id:-131;
	mso-list-type:simple;
	mso-list-template-ids:-1472961510;}
@list l1:level1
	{mso-level-tab-stop:60.45pt;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l2
	{mso-list-id:-130;
	mso-list-type:simple;
	mso-list-template-ids:-706547906;}
@list l2:level1
	{mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l3
	{mso-list-id:-129;
	mso-list-type:simple;
	mso-list-template-ids:-5577426;}
@list l3:level1
	{mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l4
	{mso-list-id:-128;
	mso-list-type:simple;
	mso-list-template-ids:-784711790;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l5
	{mso-list-id:-127;
	mso-list-type:simple;
	mso-list-template-ids:1574239950;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l6
	{mso-list-id:-126;
	mso-list-type:simple;
	mso-list-template-ids:-102330392;}
@list l6:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l7
	{mso-list-id:-125;
	mso-list-type:simple;
	mso-list-template-ids:-1758268332;}
@list l7:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l8
	{mso-list-id:-120;
	mso-list-type:simple;
	mso-list-template-ids:1384390082;}
@list l8:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l9
	{mso-list-id:-119;
	mso-list-type:simple;
	mso-list-template-ids:-1016675396;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l10
	{mso-list-id:234978892;
	mso-list-template-ids:-135476968;}
@list l10:level1
	{mso-level-text:"\[%1\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;
	mso-ansi-font-size:13.0pt;
	font-family:"Times New Roman";
	mso-ansi-font-weight:normal;
	mso-ansi-font-style:normal;}
@list l10:level2
	{mso-level-text:"%2\)";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.45in;
	mso-ansi-font-size:13.0pt;
	font-family:"Times New Roman";
	mso-ansi-font-weight:normal;
	mso-ansi-font-style:normal;}
@list l10:level3
	{mso-level-number-format:roman-lower;
	mso-level-text:"%3\)";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l10:level4
	{mso-level-number-format:alpha-lower;
	mso-level-text:"\(%4\)";
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l10:level5
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l10:level6
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l10:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l10:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l10:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l11
	{mso-list-id:248387907;
	mso-list-template-ids:-853636652;}
@list l11:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l11:level2
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l11:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l11:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l11:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l11:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:.5in;}
@list l11:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l11:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l11:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12
	{mso-list-id:339309350;
	mso-list-template-ids:-1534701368;}
@list l12:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:.5in;}
@list l12:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l12:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l13
	{mso-list-id:388502664;
	mso-list-type:simple;
	mso-list-template-ids:-1467875128;}
@list l13:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-3.5in;
	font-family:Symbol;}
@list l14
	{mso-list-id:527061025;
	mso-list-template-ids:2061530658;}
@list l14:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l14:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l14:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l14:level4
	{mso-level-reset-level:level1;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l14:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l14:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l14:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l14:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l14:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l15
	{mso-list-id:727992645;
	mso-list-template-ids:-160912838;}
@list l15:level1
	{mso-level-start-at:6;
	mso-level-style-link:"heading\: NUMBER";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l15:level2
	{mso-level-reset-level:level1;
	mso-level-style-link:"heading\: NUMBER";
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;
	mso-ansi-font-size:13.0pt;
	font-family:"Times New Roman";
	mso-ansi-font-weight:normal;
	mso-ansi-font-style:normal;}
@list l15:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l15:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l15:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l15:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:.5in;}
@list l15:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l15:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l15:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l16
	{mso-list-id:734011220;
	mso-list-template-ids:486683052;}
@list l16:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l16:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l16:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-style-link:c21;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l16:level4
	{mso-level-reset-level:level1;
	mso-level-style-link:"Body Text Indent";
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l16:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l16:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:.5in;}
@list l16:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l16:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l16:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l17
	{mso-list-id:764231896;
	mso-list-template-ids:1352008676;}
@list l17:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l17:level2
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l17:level3
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"%3\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l17:level4
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%4\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l17:level5
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l17:level6
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l17:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l17:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l17:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l18
	{mso-list-id:861017759;
	mso-list-type:hybrid;
	mso-list-template-ids:143797176 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l18:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l18:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l19
	{mso-list-id:890728182;
	mso-list-type:simple;
	mso-list-template-ids:-940518988;}
@list l19:level1
	{mso-level-text:"\[%1\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;
	mso-ansi-font-weight:normal;
	mso-ansi-font-style:normal;}
@list l20
	{mso-list-id:911693226;
	mso-list-type:simple;
	mso-list-template-ids:67698703;}
@list l20:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l21
	{mso-list-id:1041132961;
	mso-list-type:simple;
	mso-list-template-ids:67698703;}
@list l21:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l22
	{mso-list-id:1135607938;
	mso-list-type:simple;
	mso-list-template-ids:1707907966;}
@list l22:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-weight:bold;}
@list l23
	{mso-list-id:1144470410;
	mso-list-type:hybrid;
	mso-list-template-ids:-629609412 -186586008 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l23:level1
	{mso-level-start-at:2;
	mso-level-number-format:alpha-lower;
	mso-level-text:"\(%1\)";
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l24
	{mso-list-id:1207377213;
	mso-list-template-ids:43184580;}
@list l24:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;
	mso-ansi-font-size:12.0pt;}
@list l24:level2
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%2\)";
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l24:level3
	{mso-level-number-format:roman-lower;
	mso-level-text:"%3\)";
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l24:level4
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%4\)";
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l24:level5
	{mso-level-text:"\(%5\)";
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l24:level6
	{mso-level-number-format:alpha-lower;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l24:level7
	{mso-level-number-format:roman-lower;
	mso-level-text:"\(%7\)";
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l24:level8
	{mso-level-number-format:alpha-lower;
	mso-level-text:"\(%8\)";
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l24:level9
	{mso-level-number-format:roman-lower;
	mso-level-text:"\(%9\)";
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l25
	{mso-list-id:1236354383;
	mso-list-type:simple;
	mso-list-template-ids:-225288742;}
@list l25:level1
	{mso-level-text:"\[%1\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;
	mso-ansi-font-weight:normal;
	mso-ansi-font-style:normal;}
@list l26
	{mso-list-id:1250120100;
	mso-list-template-ids:-2020592624;
	mso-list-name:QUOTE;}
@list l26:level1
	{mso-level-number-format:none;
	mso-level-text:"";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l26:level2
	{mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l26:level3
	{mso-level-number-format:none;
	mso-level-text:%3;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l26:level4
	{mso-level-suffix:none;
	mso-level-text:"\(%4\)\0009";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l26:level5
	{mso-level-number-format:roman-lower;
	mso-level-text:"\(%5\)\0009";
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l26:level6
	{mso-level-number-format:roman-lower;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l26:level7
	{mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l26:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l26:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l27
	{mso-list-id:1296107855;
	mso-list-type:simple;
	mso-list-template-ids:-1612034996;}
@list l27:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l28
	{mso-list-id:1297906242;
	mso-list-type:hybrid;
	mso-list-template-ids:567474284 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l28:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l29
	{mso-list-id:1315601249;
	mso-list-type:simple;
	mso-list-template-ids:-52672024;}
@list l29:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l30
	{mso-list-id:1383941449;
	mso-list-type:simple;
	mso-list-template-ids:67698703;}
@list l30:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l31
	{mso-list-id:1509170297;
	mso-list-template-ids:-1137539842;}
@list l31:level1
	{mso-level-text:"\[%1\]     ";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l31:level2
	{mso-level-number-format:none;
	mso-level-text:%2;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l31:level3
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%3\)";
	mso-level-tab-stop:.9in;
	mso-level-number-position:left;
	text-indent:-.4in;}
@list l31:level4
	{mso-level-text:"%4\)";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l31:level5
	{mso-level-text:%5;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l31:level6
	{mso-level-text:%6;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l31:level7
	{mso-level-text:%7;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l31:level8
	{mso-level-text:%8;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l31:level9
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l32
	{mso-list-id:1550385919;
	mso-list-template-ids:821708086;}
@list l32:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l32:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l32:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l32:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l32:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l32:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l32:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l32:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l32:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l33
	{mso-list-id:1665664019;
	mso-list-template-ids:-1754337048;}
@list l33:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l33:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l33:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l33:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l33:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l33:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l33:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l33:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l33:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l34
	{mso-list-id:1682200304;
	mso-list-template-ids:426402662;}
@list l34:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l34:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l34:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l34:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l34:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l34:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:.5in;}
@list l34:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l34:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l34:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l35
	{mso-list-id:1782457026;
	mso-list-type:simple;
	mso-list-template-ids:1131831968;}
@list l35:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l36
	{mso-list-id:1785883979;
	mso-list-template-ids:1689811090;}
@list l36:level1
	{mso-level-number-format:alpha-lower;
	mso-level-text:"\(%1\)";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l36:level2
	{mso-level-number-format:none;
	mso-level-text:%2;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l36:level3
	{mso-level-number-format:alpha-lower;
	mso-level-text:"\(%3\)";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l36:level4
	{mso-level-number-format:none;
	mso-level-text:"\(i\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:.5in;}
@list l36:level5
	{mso-level-text:%5;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l36:level6
	{mso-level-text:%6;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l36:level7
	{mso-level-text:%7;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l36:level8
	{mso-level-text:%8;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l36:level9
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l37
	{mso-list-id:1816682448;
	mso-list-template-ids:-784801062;}
@list l37:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l37:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l37:level3
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-text:"%3\)";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l37:level4
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-text:"\(%4\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l37:level5
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l37:level6
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l37:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l37:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l37:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l38
	{mso-list-id:1860773060;
	mso-list-type:simple;
	mso-list-template-ids:1515980402;}
@list l38:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-weight:bold;}
@list l39
	{mso-list-id:1869180514;
	mso-list-template-ids:-1483452776;}
@list l39:level1
	{mso-level-number-format:roman-lower;
	mso-level-text:"\(%1\)";
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.5in;}
@list l39:level2
	{mso-level-number-format:alpha-lower;
	mso-level-text:"\(%2\)";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l39:level3
	{mso-level-number-format:roman-lower;
	mso-level-text:"\(%3\)";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l39:level4
	{mso-level-text:"\(%4\)";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l39:level5
	{mso-level-number-format:alpha-lower;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l39:level6
	{mso-level-number-format:roman-lower;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l39:level7
	{mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l39:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l39:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l40
	{mso-list-id:2059817004;
	mso-list-template-ids:-1213419456;}
@list l40:level1
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l40:level2
	{mso-level-reset-level:level1;
	mso-level-text:"\[%2\]";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l40:level3
	{mso-level-number-format:none;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:%3;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l40:level4
	{mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l40:level5
	{mso-level-number-format:alpha-lower;
	mso-level-reset-level:level1;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	text-indent:0in;}
@list l40:level6
	{mso-level-number-format:roman-lower;
	mso-level-reset-level:level1;
	mso-level-suffix:none;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l40:level7
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l40:level8
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l40:level9
	{mso-level-number-format:none;
	mso-level-suffix:none;
	mso-level-text:%9;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:0in;}
@list l41
	{mso-list-id:2077392087;
	mso-list-type:simple;
	mso-list-template-ids:67698703;}
@list l41:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	text-indent:-.25in;}
ol
	{ul
	{-->
</style>
</head>
<body bgcolor="#FFFFFF" style='tab-interval:.5in' lang=EN-CA>
<div class=Section1> 
  <p class=MsoNormal align=right style='text-align:right'><b style='mso-bidi-font-weight:
normal'>DATE: 20050607<br>
    </b><b style='mso-bidi-font-weight:
normal'>DOCKET: C42093, C42657 &amp; C42658</b></p>
  <h2>COURT OF APPEAL FOR ONTARIO</h2>
  <h4 align=center style='text-align:center'><span lang=EN-US>WEILER, ROSENBERG 
    and LANG JJ.A.</span></h4>
  <table border=0 align="center" cellpadding=0 cellspacing=0 style='border-collapse:collapse;
 mso-padding-alt:0in 5.4pt 0in 5.4pt'>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b style='mso-bidi-font-weight:normal'>B E T W E E 
          N :</b></p></td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b style='mso-bidi-font-weight:normal'>JANSSEN-ORTHO 
          INC.<br>
          Plaintiff/Appellant/Respondent on Cross-Appeal/Respondent on Appeal 
          Transferred from Divisional Court </b></p></td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b style='mso-bidi-font-weight:normal'>Kathryn Podrebarac 
          and<br>
          </b><b style='mso-bidi-font-weight:normal'>Jennifer Lynch<br>
          for Janssen-Ortho Inc. </b></p></td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b style='mso-bidi-font-weight:normal'>- and -</b></p></td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal>&nbsp;</p></td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal>&nbsp;</p></td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b style='mso-bidi-font-weight:normal'>AMGEN CANADA 
          INC. and KARISMA CANADA INC.<br>
          Defendants/Respondents/Cross-Appellants/Appellants on Appeal Transferred 
          from Divisional Court </b></p></td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b style='mso-bidi-font-weight:normal'>Rocco Di Pucchio 
          for Amgen Canada Inc.</b></p>
        <p class=MsoNormal><b style='mso-bidi-font-weight:normal'>Dominic Campione<br>
          </b><b style='mso-bidi-font-weight:normal'>for Karisma Canada Inc.</b></p></td>
    </tr>
    <tr> 
      <td width=313 valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
      <td width=300 valign=top style='width:225.0pt;padding:0in 5.4pt 0in 5.4pt'>&nbsp; 
      </td>
    </tr>
    <tr> 
      <td colspan="2" valign=top style='width:234.9pt;padding:0in 5.4pt 0in 5.4pt'> 
        <p class=MsoNormal><b style='mso-bidi-font-weight:normal'>Heard:<span
  style="mso-spacerun: yes">  </span>April 22, 2005</b></p></td>
    </tr>
  </table>
  <h4 style='line-height:normal'><span lang=EN-US>On appeal from the orders of 
    Justice Sarah E. Pepall of the Superior Court of Justice dated June 10, 2004, 
    reasons reported at [2004] O.J. No. 2523.</span></h4>
  <h4 style='line-height:normal'><span lang=EN-US>WEILER J.A.:</span></h4>
  <p class=headingNUMBER style='line-height:normal'> [1]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Section 5(1) of the <i>Libel and Slander Act</i>, R.S.O. 1990, c. 
    L.12<i> </i>(the “Act”) provides, “No action…lies” for defamatory words in 
    a newspaper or in a broadcast unless the plaintiff has given notice in writing 
    to the defendant of the alleged defamation within six weeks from the time 
    the plaintiff had knowledge of it.</p>
  <p class=headingNUMBER style='line-height:normal'> [2]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The alleged defamation in this case began with two radio broadcasts 
    that occurred on March&nbsp;12 and March 16, 2003, that were simultaneously 
    broadcast on the Internet.<span style="mso-spacerun: yes">  </span>I will 
    refer to them collectively as the March broadcasts. On March 26, 2003, a Member 
    of the House of Commons raised a question in Parliament based on the allegedly 
    libellous broadcasts. </p>
  <p class=headingNUMBER style='line-height:normal'> [3]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> As a result of the March broadcast and the question in Parliament, 
    the plaintiff Janssen-Ortho Inc. (“Janssen”) served a statement of claim on 
    the defendants Amgen Canada Inc. (“Amgen”) and Karisma Canada Inc. (“Karisma”) 
    on April 2, 2003, which claimed damages of $10,000,000.<span
style="mso-spacerun: yes">  </span>The claim alleged several causes of action, 
    including defamation.<span style="mso-spacerun: yes">  </span>At the same 
    time, Janssen served a motion record seeking an injunction.<span style="mso-spacerun:
yes">  </span>On May 15, Janssen officially served a notice purporting to comply 
    with s.&nbsp;5(1) of the Act<i>.<span style="mso-spacerun: yes">  </span></i>On 
    June 12, 2003, Janssen served a second statement of claim repeating the defamation 
    allegations from its first statement of claim and adding a further allegation 
    of defamation as a result of an article in Frank magazine.</p>
  <p class=headingNUMBER style='line-height:normal'> [4]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The first issue in this appeal is whether the initiation of the April 
    2 litigation complied with s. 5(1) of the Act.<span
style="mso-spacerun: yes">  </span>Janssen acknowledges that the existing jurisprudence 
    from this court requires the plaintiff to give notice to non-media defendants 
    as well as to media defendants; however, Janssen asks us to reconsider this 
    jurisprudence.<span style="mso-spacerun: yes">  </span>Alternatively, if notice 
    to non&#8209;media defendants is required, Janssen submits that the motion 
    record served on April 2, 2003, constituted notice.<span style="mso-spacerun: yes">  
    </span>A further alternative argument is that the April 2 statement of claim 
    constituted the requisite notice within sixty days for the radio broadcasts 
    and salvages the June 12 statement of claim.</p>
  <p class=headingNUMBER style='line-height:normal'> [5]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In addition to the substantive issues, Janssen raised procedural issues 
    that require consideration of the <i>Rules of Civil Procedure</i>, R.R.O. 
    1990, Reg. 194, including rule 21.01(1)(b), providing for a motion to strike 
    out a pleading as disclosing no reasonable cause of action; rule 21.01(1)(a), 
    providing for a motion to determine a question of law; and rule 51.06(1), 
    providing for an order resulting from an admission.<span
style="mso-spacerun: yes">  </span></p>
  <p class=headingNUMBER style='line-height:normal'> <span
lang=EN-US style='mso-ansi-language:EN-US'>[6]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> <span lang=EN-US style='mso-ansi-language:EN-US'>Having regard 
    to the jurisprudence respecting s. 5(1) of the Act, the motions judge struck 
    the claim in defamation relating to the March broadcasts from the April 2 
    statement of claim and I would uphold her conclusion in this regard.<span
style="mso-spacerun: yes">  </span>Because certain allegedly defamatory e&#8209;mails 
    sent by Karisma are neither a broadcast or a newspaper and the s. 5(1) notice 
    requirement does not apply to them, I would, however, stay that portion of 
    the judgment striking the claim in defamation for thirty days so that, if 
    Janssen wishes to do so, it may move on proper material before a judge of 
    the Superior Court for leave to amend its pleading respecting the e&#8209;mails. 
    </span></p>
  <p class=headingNUMBER style='line-height:normal'> <span
lang=EN-US style='mso-ansi-language:EN-US'>[7]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> <span lang=EN-US style='mso-ansi-language:EN-US'>The motions 
    judge refused to strike the June 12 statement of claim in relation to the 
    March broadcasts on the basis that it was not plain and obvious that the paragraphs 
    relating to the March broadcasts disclosed no cause of action.<span
style="mso-spacerun: yes">  </span>I disagree with her and would hold that the 
    commencement of a second action on June 12 cannot salvage the defamation action 
    respecting the March broadcasts.<span style="mso-spacerun: yes">  </span>In 
    view of my conclusion, it is not necessary to address whether the motions 
    judge’s refusal to strike the June 12 claim as frivolous, vexatious or an 
    abuse of process was a final order.<span style="mso-spacerun: yes">  </span></span></p>
  <p class=headingNUMBER style='line-height:normal'> [8]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Janssen also sued Amgen and Karisma in defamation due to the Member’s 
    question in Parliament and, although the Member was not sued, the motions 
    judge struck the pleading in both statements of claim on the basis of parliamentary 
    privilege.<span style="mso-spacerun: yes">  </span>A subsidiary issue on this 
    appeal is the extent of parliamentary privilege and whether the motions judge 
    erred in striking the portion of the pleading relating to the Member’s question 
    in Parliament.<span style="mso-spacerun: yes">  </span>I would hold that the 
    motions judge did not err.<span style="mso-spacerun: yes">  </span></p>
  <h4 style='line-height:normal'><span lang=EN-US>The Factual Matrix Alleged</span></h4>
  <p class=headingNUMBER style='line-height:normal'> [9]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The factual matrix in paragraphs 9-14 of these reasons is largely 
    drawn from the allegations in Janssen’s statements of claim and Karisma’s 
    statement of defence.<span style="mso-spacerun: yes">  </span>Amgen has yet 
    to file a statement of defence.</p>
  <p class=headingNUMBER style='line-height:normal'> [10]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Janssen markets in Canada a drug called EPREX, which stimulates the 
    production of red blood cells in patients with anaemia.<span
style="mso-spacerun: yes">  </span>Amgen, a competitor of Janssen, markets the 
    only competing drug, which was launched in the Canadian market in August 2002.<span style="mso-spacerun: yes">  
    </span>Karisma is a public relations firm that was retained by Amgen in February 
    2003 to assist in marketing and promoting its competing drug<span style="mso-spacerun: yes">  
    </span></p>
  <p class=headingNUMBER style='line-height:normal'> [11]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> On June 25, 2002, in consultation with and with the approval of Health 
    Canada, Janssen issued a “Dear Healthcare Professional” letter regarding reports 
    of a rare but serious condition, called pure red cell aplasia (“PRCA”), in 
    chronic kidney disease patients treated with EPREX subcutaneously.<span style="mso-spacerun: yes">  
    </span>The letter recommends intravenous administration of EPREX for these 
    patients where feasible.<span
style="mso-spacerun: yes">  </span>In July 2002, the European Union Member States 
    (EU) issued a similar letter, and in December 2002 a further letter from the 
    EU contraindicated the subcutaneous administration of EPREX in chronic kidney 
    disease patients.<span style="mso-spacerun: yes">  </span>This change did 
    not affect the other approved uses of EPREX.</p>
  <p class=headingNUMBER style='line-height:normal'> [12]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> On March 12, 2003, the radio station CFTR (680 News All News Radio) 
    broadcast from Toronto and simultaneously on the Internet the news that EPREX 
    was connected to thirty-seven deaths in Canada.<span style="mso-spacerun:
yes">  </span>The report concluded, “Canada is the only country that has not recommended 
    that EPREX be removed”.</p>
  <p class=headingNUMBER style='line-height:normal'> [13]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> On March 16, 2003, Peter Warren broadcast in major Canadian cities 
    on the Corus Radio Network the statement that “a lot of other countries have 
    withdrawn EPREX from the market”.<span style="mso-spacerun: yes">  </span>Following 
    a written complaint by Janssen, he broadcast a correction one week later confirming 
    that EPREX had not been withdrawn from any market.<span
style="mso-spacerun: yes">  </span></p>
  <p class=headingNUMBER style='line-height:normal'> [14]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In response to Janssen’s investigations about the origin of CFTR’s 
    erroneous broadcast, CFTR forwarded a copy of an e-mail sent by Michelle Brun 
    of Karisma to the CFTR reporter, Marlane Oliver, dated March 10, 2003.<span style="mso-spacerun: yes">  
    </span>The e-mail states that health authorities in Europe and Australia decided 
    that EPREX should not be used subcutaneously for patients with chronic kidney 
    disease because it had been associated with PRCA, that one hundred forty-one 
    cases had been reported worldwide, and that thirty-seven cases were Canadian.<span style="mso-spacerun:
yes">  </span>The e-mail concluded, “The story is that Canada has yet to take 
    action.<span style="mso-spacerun: yes">  </span>In fact, they are the ONLY 
    country who has not recommended removal of EPREX.” </p>
  <p class=headingNUMBER style='line-height:normal'> [15]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> On March 26, 2003, Member of Parliament Svend Robinson asked the House 
    during Question Period, “Why won’t this Minister join many other countries 
    in Europe and Australia in contraindicating the use of EPREX in Canada?<span style="mso-spacerun: yes">  
    </span>Or will it take another death before the Minister finally acts?”</p>
  <p class=headingNUMBER style='line-height:normal'> [16]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Janssen alleges that the media disseminations are incorrect and misleading 
    for several reasons including the facts that EPREX has not been connected 
    with thirty-seven deaths in Canada and that no country has recommended that 
    EPREX be removed from the market.</p>
  <p class=headingNUMBER style='line-height:normal'> [17]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> On April 2, 2003, Janssen issued a statement of claim in which it 
    named Amgen and Karisma as defendants.<span style="mso-spacerun: yes">  </span>In 
    the statement of claim, Janssen alleged six causes of action, one of which 
    was defamation.<span style="mso-spacerun: yes">  </span>At the same time, 
    Janssen served a motion record seeking an injunction against Amgen and Karisma.<span style="mso-spacerun: yes">  
    </span>In support of the motion, Janssen filed the affidavit of Dr. Wendy 
    Arnott, vice&#8209;president of Regulatory, Quality Medical and Linguistic 
    Services for Janssen, dated April 2.</p>
  <p class=headingNUMBER style='line-height:normal'> [18]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> On April 15, 2003, Karisma filed a statement of defence, which it 
    amended on April 17. Karisma stated Amgen retained it to help promote information 
    about:</p>
  <p class=Doubleindent-quote>the risks inherent in the subcutaneous (under the 
    skin) administration of Eprex in patients with chronic renal failure and the 
    fact that a number of EU states had contraindicated administration of the 
    drug subcutaneously.</p>
  <p class=ParaNO style='line-height:normal'>Karisma denied advising the CFTR 
    broadcaster that there had been thirty-seven deaths and states that within 
    one hour of the broadcast it advised the broadcaster that “cases” did not 
    necessarily mean “deaths”.<span style="mso-spacerun: yes">  </span>Karisma 
    admitted, however, that it erred in advising Oliver and Warren that EPREX 
    had been recommended for removal from the market in countries outside of Canada.<span style="mso-spacerun: yes">  
    </span>Its pleading characterized this error as “an honest mistake” and “without 
    nefarious intent”.<span
style="mso-spacerun: yes">  </span>In an action for defamation, it is not generally 
    necessary to prove malice, only falsity: see <i>Adam v. Ward</i>, [1917] A.C. 
    309 (U.K. H.L.).</p>
  <p class=headingNUMBER style='line-height:normal'> [19]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> When Dr. Arnott was cross-examined on April 29, 2003, on her affidavit 
    of April 2 and her further affidavit of April 20, she admitted that no notice 
    had been delivered under s. 5(1) of the Act<i>.</i> </p>
  <p class=headingNUMBER style='line-height:normal'> [20]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> On May 21, 2003, Nordheimer J. dismissed the motion for an injunction 
    on the basis that he was not satisfied that irreparable harm was shown.<span style="mso-spacerun: yes">  
    </span>He also expressed concern that the relief requested was vague and overbroad.</p>
  <p class=headingNUMBER style='line-height:normal'> [21]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> On May 15, Ms. Podrebarac, counsel for Janssen, wrote a letter to 
    counsel for Amgen and Karisma that reads, in part:</p>
  <p class=Doubleindent-quote>In Mr. Di Pucchio’s [counsel for Amgen’s] submissions 
    to Justice Nordheimer (and in Amgen’s supporting factum) he correctly stated 
    that a libel notice under Ontario’s <i>Libel and Slander Act </i>had not yet 
    been served on the defendants.</p>
  <p class=Doubleindent-quote>As Ms. Tough indicated in her reply submissions, 
    given that Amgen/Karisma’s campaign against EPREX® was a deliberately covert 
    operation, it was not immediately apparent who, if anyone, was behind the 
    erroneous broadcasts on CFTR and on the Peter Warren Show.<span
style="mso-spacerun: yes">  </span></p>
  <p class=Doubleindent-quote>Enclosed please find a Notice under section 5 of 
    the <i>Act</i> relating to these broadcasts.</p>
  <p class=headingNUMBER style='line-height:normal'> [22]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> On May 28, 2003, Janssen’s counsel qualified this admission in a letter 
    to both Amgen and Karisma.<span style="mso-spacerun: yes">  </span>The letter 
    reads in part as follows:</p>
  <p class=Doubleindent-quote>You may regard this letter as a qualification to 
    the answer to Question 214 posed on the Cross-Examination of Dr. Arnott, held 
    April 29, 2003 <i>and a qualification to the first paragraph of my letter 
    to you dated May 15, 2003, which was also addressed to Karisma Canada Inc.’s 
    prior counsel, Mr. Blaier.<span style="mso-spacerun: yes">  </span></i>In 
    other words, while no document entitled “Notice” under the <i>Act</i> was 
    delivered prior to letters dated May 15 and 23, 2003, the motion record and 
    claim satisfy the s.5(1) notice requirements in respect of a subsequent action. 
  </p>
  <p class=Doubleindent-quote>As I advised Mr. Gruber, my client intends to bring 
    a fresh action, which will be restricted to the libel claims.<span style="mso-spacerun: yes">  
    </span>As I also advised Mr. Gruber, it is our intent to amend the Statement 
    of Claim to remove the allegation of libel in our current action, and to bring 
    a motion (if your clients do not consent) to have the current action and the 
    fresh action consolidated or heard at the same time [emphasis added].</p>
  <p class=headingNUMBER style='line-height:normal'> [23]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Janssen issued a second statement of claim on June 12, 2003, alleging 
    only defamation and repeating the allegations from its April statement of 
    claim.<span style="mso-spacerun: yes">  </span>There were, however, two substantive 
    differences.<span style="mso-spacerun: yes">  </span>First, the June 12 claim 
    contained an additional allegation of defamation relating to an article that 
    appeared in Frank Magazine on May&nbsp;15, 2003, entitled “Health Canada neglects 
    EPREX RX effects?”<span style="mso-spacerun: yes">  </span>The article contained 
    the statement, <i>inter alia</i>, that “[H]ealth authorities in the European 
    Union and Australia…late last year banned the use of Eprex”.<span style="mso-spacerun: yes">  
    </span>Prior to issuing this statement of claim, Janssen served a s. 5(1) 
    notice under the Act on Amgen and Karisma dated May&nbsp;23, 2003, respecting 
    the Frank Magazine article.<span
style="mso-spacerun: yes">  </span>Second, whereas the April 2 statement of claim 
    was silent with respect to compliance with s. 5(1) of the Act,<i> </i>paragraph&nbsp;47 
    of the June 12 statement of claim alleged service of such a notice.</p>
  <p class=headingNUMBER style='line-height:normal'> [24]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Amgen requested particulars of the alleged notice in writing dated 
    April 2, 2003.<span style="mso-spacerun: yes">  </span>Janssen’s response 
    to Amgen’s demand for particulars was:</p>
  <p class=Doubleindent-quote>[N]otice in writing specifying the matters complained 
    of as prescribed by Section 5 of the <i>Libel and Slander Act </i>was served 
    personally on each of the Defendants on April 2, 2003, in the form of the 
    Plaintiff’s Motion Record in support of an interim, interlocutory and permanent 
    injunction, which was served at the same time as the Statement of Claim.<span style="mso-spacerun: yes">  
    </span></p>
  <p class=headingNUMBER style='line-height:normal'> [25]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> <span style="mso-spacerun: yes"> </span>Although Janssen’s counsel 
    indicated in her May 28 letter that she intended to discontinue the April 
    2 action with respect to defamation, this was not done.<span
style="mso-spacerun: yes">  </span>On August&nbsp;25, 2003, Janssen amended its 
    April 2 statement of claim to further allege defamation respecting the article 
    in Frank Magazine. </p>
  <p class=headingNUMBER style='line-height:normal'> [26]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Amgen brought a motion to strike the defamation claims from the April 
    2 statement of claim as amended as disclosing no cause of action because a 
    notice was not served in accordance with s. 5(1) of the Act.<span
style="mso-spacerun: yes">  </span>Amgen alternatively requested the determination 
    of a question of law, asking whether Janssen’s claim was statute barred due 
    to Janssen’s failure to deliver a notice in accordance with s. 5(1).<span style="mso-spacerun: yes">  
    </span>It also sought an order dismissing the June 12 statement of claim in 
    its entirety on the basis that it was frivolous and vexatious or on the basis 
    that another proceeding was pending respecting the same subject matter pursuant 
    to rules 25.11(b) and (c) and s. 138 of the <i>Courts of Justice Act</i>, 
    R.S.O. 1990, c. C.43.<span
style="mso-spacerun: yes">  </span>Under the heading “The Grounds for the Motion 
    Are”, Amgen stated:</p>
  <p class=Doubleindent-quote>a) The Plaintiff <i>has admitted</i> in this proceeding 
    that it did not provide a notice regarding the allegations of defamation contained 
    in paragraphs 26 to 32 of the <u>Amended</u> Statement of Claim as required 
    under section 5 of the <i>Libel and Slander Act.</i></p>
  <p class=Doubleindent-quote>b) In the alternative, the Plaintiff <i>has admitted 
    in its Reply to a Demand for Particulars </i>served in connection with a second 
    Statement of Claim (Court File No. 03-CV-250532-CM1) issued against these 
    same defendants that it did not deliver the Section 5 Libel Notice prior to 
    commencing the action.</p>
  <p class=ParaNO style='line-height:normal'>Amgen relied on rules <a
name="OLE_LINK1">21.01(1)</a>(a) (determination of a question of law) and 21.01(1)(b) 
    (pleading discloses no reasonable cause of action); 25.11(b) (pleading is 
    scandalous, frivolous or vexatious) and 25.11(c) (pleading is an abuse of 
    process); and 56.01(1)(c) (order for costs in the same proceeding remain unpaid)(<i>quaere</i> 
    whether Amgen meant to refer to rule 51.06 respecting admissions).<i></i></p>
  <p class=headingNUMBER style='line-height:normal'> [27]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Karisma brought a similar motion to strike out the paragraphs of the 
    amended statement of claim as disclosing no reasonable cause of action on 
    the basis that they were scandalous, frivolous, or<span style="mso-spacerun:
yes">  </span>vexatious, as well as for determination of a question of law.<span style="mso-spacerun: yes">  
    </span>Under the heading, “The Grounds for the motion are”, it too relied 
    on Janssen’s admission and on the reply to the demand for particulars.</p>
  <p class=headingNUMBER style='line-height:normal'> [28]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Janssen brought a cross-motion under Rule 6 seeking that the action 
    in its June 12 statement of claim be consolidated, case-managed, and tried 
    together with the action begun on April 2.<span style="mso-spacerun:
yes">  </span>Janssen’s counsel did not appreciate that the amended statement 
    of claim continued to contain claims for defamation and when the motions were 
    argued this became apparent.</p>
  <h4 style='line-height:normal'><span lang=EN-US>The Order of the Motions Judge 
    </span></h4>
  <p class=headingNUMBER style='line-height:normal'> [29]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The three motions were heard together by the motions judge.<span style="mso-spacerun: yes">  
    </span>She struck the paragraphs pleading defamation in the April 2 statement 
    of claim as amended.<span
style="mso-spacerun: yes">  </span>However, she left intact the paragraphs setting 
    out the alleged facts relating to the two broadcasts as these same facts also 
    grounded some of the other claims in that statement of claim.<span
style="mso-spacerun: yes">  </span>She dismissed Amgen’s and Karisma’s motions 
    in relation to the June 12 statement of claim and refused to dismiss the June 
    12 action as being frivolous, vexatious, or an abuse of process.<span
style="mso-spacerun: yes">  </span>She also dismissed Janssen’s motion for consolidation 
    “without prejudice to [Janssen’s] ability to bring the motion again after 
    the close of pleadings”.</p>
  <h4 style='line-height:normal'><span lang=EN-US>The Appeals</span></h4>
  <p class=headingNUMBER style='line-height:normal'> [30]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Janssen appeals to the Court of Appeal the striking of its claim for 
    defamation in the April 2 statement of claim.<span
style="mso-spacerun: yes">  </span>Amgen and Karisma cross-appeal on the basis 
    that the motions judge erred in dismissing their motions to dismiss the second 
    action as being frivolous, vexatious, or an abuse of process.<span
style="mso-spacerun: yes">  </span>Because the motions judge’s order precluded 
    any further argument on the issues in circumstances where the defence would 
    have been determinative of the entire action, Amgen and Karisma submit that 
    her order was a final order.<span style="mso-spacerun: yes">  </span>They 
    rely on <i>Abbott v. Collins</i> (2002), 62 O.R. (3d) 99 at 101 (C.A.).<span style="mso-spacerun:
yes">  </span></p>
  <p class=headingNUMBER style='line-height:normal'> [31]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Amgen and Karisma also sought leave to appeal to the Divisional Court 
    the motions judge’s refusal to strike the paragraphs setting out the alleged 
    facts relating to the two broadcasts in the April 2 statement of claim.<span style="mso-spacerun: yes">  
    </span>Ground J. refused leave on the basis that there was no good reason 
    to doubt the correctness of her exercise of discretion.<span style="mso-spacerun: yes">  
    </span>With respect to her order dismissing the motion to strike the June 
    12 claim in its entirety as an abuse of process or on the basis of a multiplicity 
    of proceedings, he also held there was no error in principle in the exercise 
    of her discretion and refused leave.<span style="mso-spacerun: yes">  </span>However, 
    he granted leave from her order declining to strike the paragraphs relating 
    to the March broadcasts in the June 12 action.<span style="mso-spacerun: yes">  
    </span>He held at para. 12:</p>
  <p class=Doubleindent-quote>There is also ample authority for the proposition 
    that the notice [pursuant&nbsp;to&nbsp;s.&nbsp;5] must be given prior to the 
    commencement of the proceeding and that the Statement of Claim in a proceeding 
    cannot constitute notice for purposes of Section 5 of the <i>Libel Act.<span style="mso-spacerun: yes">  
    </span></i>Accordingly, in my view, there is good reason to doubt the correctness 
    of Pepall&nbsp;J.’s Order in this regard.<span style="mso-spacerun: yes">  
    </span>In addition, it does not appear that the essential question of whether 
    a claim in defamation can be salvaged by the commencement of a second proceeding 
    after failure to provide a Section 5 Notice in a first proceeding has ever 
    been addressed by the courts in this province.<span style="mso-spacerun: yes">  
    </span>In my view this is an issue of some importance to the administration 
    of justice and the development of the law in that it could affect any libel 
    proceeding in this province where there has been a failure to provide a Section 
    5 Notice prior to the commencement of the proceeding.</p>
  <p class=ParaNO style='line-height:normal'>On consent, the appeal was then transferred 
    from the Divisional Court to this court to be heard with the appeal and cross-appeal.</p>
  <h4 style='line-height:normal'><span lang=EN-US>ISSUES</span></h4>
  <p class=headingNUMBER style='line-height:normal'> [32]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Janssen’s appeal raises seven issues:</p>
  <p class=ParaNO style='line-height:normal;
mso-list:l15 level4 lfo70'> 1. <span
style='mso-tab-count:1'> </span>Does the s. 5(1) requirement to deliver a defamation 
    notice apply to non&#8209;media defendants?</p>
  <p class=ParaNO style='line-height:normal;
mso-list:l15 level4 lfo70'> 2. <span
style='mso-tab-count:1'> </span>Were the preconditions to s. 5(1) met?</p>
  <p class=ParaNO style='line-height:normal;
mso-list:l15 level4 lfo70'> 3. <span
style='mso-tab-count:1'> </span>Did the April 2 statement of claim comply with 
    s. 5(1)? </p>
  <p class=ParaNO style='line-height:normal;
mso-list:l15 level4 lfo70'> 4. <span
style='mso-tab-count:1'> </span>Was the motions judge entitled to strike the April 
    2 claim against Amgen on the basis of rule 51.06?</p>
  <p class=ParaNO style='line-height:normal;
mso-list:l15 level4 lfo70'> 5. <span
style='mso-tab-count:1'> </span>Did the motions judge err in holding that Karisma 
    could not rely on rule 51.06?</p>
  <p class=ParaNO style='line-height:normal;
mso-list:l15 level4 lfo70'> 6. <span
style='mso-tab-count:1'> </span>Was the motions judge entitled to strike the April 
    2 claim against Karisma on the basis of rule 21.01(1)(a)?</p>
  <p class=ParaNO style='line-height:normal;
mso-list:l15 level4 lfo70'> 7. <span
style='mso-tab-count:1'> </span>Did the motions judge err in striking out the 
    references in Janssen’s claim for defamation to the comments made by Member 
    of Parliament Svend Robinson?</p>
  <p class=headingNUMBER style='line-height:normal'> <span
lang=EN-US style='mso-ansi-language:EN-US'>[33]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> The issue on Amgen and Karisma’s cross-appeal is whether the 
    motions judge’s refusal to strike the June 12 claim as frivolous, vexations, 
    or an abuse of process was a final order and, if so, whether the motions judge 
    erred in not striking the claim on this basis.<span
style="mso-spacerun: yes">  </span>Amgen and Karisma’s appeal transferred from 
    the Divisional Court raises the issue of whether the motion judge erred in 
    refusing to strike certain paragraphs in the June&nbsp;12 statement of claim 
    because it was not plain and obvious that no s.&nbsp;5(1) notice was provided.</p>
  <h4 style='line-height:normal'><span lang=EN-US>ANALYSIS</span></h4>
  <h4 style='line-height:normal'><span
lang=EN-US>A.<span style='mso-tab-count:1'>      </span>Janssen’s Appeal</span></h4>
  <h4 style='line-height:normal'><span
lang=EN-US>1. Does the s. 5(1) requirement to deliver a defamation notice apply 
    to non&#8209;media defendants?</span></h4>
  <p class=headingNUMBER style='line-height:normal'> [34]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In <i>Watson v. Southam Inc.</i> (2000), 189 D.L.R. (4th) 695 (Ont. 
    C.A.); 134 O.A.C. 139, this court decided that s. 5(1) applies to both media 
    and non-media defendants.<span style="mso-spacerun: yes">  </span>The court 
    also decided that the notice must be served before litigation commences.<span
style="mso-spacerun: yes">  </span>Janssen invites this court to reconsider its 
    decision in this case in light of Doherty J.A.’s <i>obiter </i>comment in 
    <i>Roach v. Now Communications</i>, <span lang=EN-US style='mso-ansi-language:EN-US'>[2002] 
    O.J. No. 875 (C.A.) </span>that the law respecting notice to non-media defendants 
    may have to be reconsidered.<span style="mso-spacerun: yes">  </span>In support 
    of its position Janssen relies on Professor Brown’s critique in <i>The Law 
    of Defamation in Canada</i>, vol. 3, 2d ed. looseleaf (Toronto: Carswell, 
    2004) at heading 17.3(2)(b)(i)(C).<span style="mso-spacerun: yes">   </span></p>
  <p class=headingNUMBER style='line-height:normal'> [35]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Professor Brown is of the opinion that the context of the other provisions 
    in the Act indicates that the legislature did not intend the notice provisions 
    to apply to non-media defendants and makes a number of other arguments in 
    support of his position. However, he opines that the word defendant in conjunction 
    with the words “newspaper” and “broadcaster” should be given a large and liberal 
    construction that includes within their ambit “<i>all those who have some 
    responsibility for the appearance of a libel in a newspaper or broadcast</i>” 
    (emphasis added).<span style="mso-spacerun: yes">  </span>In addition to reporters 
    and other authors employed directly by the newspaper, he states: </p>
  <p class=Doubleindent-quote>[The term] could also include freelance authors 
    or persons who submit letters for publication or telephone in comments for 
    a broadcast, or appear as a guest in a broadcast program, but this is more 
    tenuous. <span style="mso-spacerun: yes"> </span></p>
  <p class=headingNUMBER style='line-height:normal'> [36]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> <span style="mso-spacerun: yes"> </span>Indeed, a man calling a radio 
    phone-in show who allegedly made defamatory comments during the program’s 
    broadcast was the subject of a lawsuit in <i>Emonts v. McKeever</i>, [1992] 
    O.J. No. 1467. Although the broadcaster was not sued, Goodearle J. held that 
    the defendant was entitled to “have equal access to the prescriptive shield 
    offered” in s. 5(1) of the Act. </p>
  <p class=headingNUMBER style='line-height:normal'> [37]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In this case, the broadcasters did not fortuitously report comments 
    that they heard.<span style="mso-spacerun: yes">  </span>Instead, Karisma 
    sent an e&#8209;mail about Janssen’s product to a CFTR reporter for broadcast.<span style="mso-spacerun: yes">  
    </span>Thus, even assuming the validity of Professor Brown’s critique, Karisma, 
    and its principal, Amgen, could come within the ambit of the construction 
    of “broadcaster” proposed by Professor Brown, namely, a person having some 
    responsibility for the appearance of the defamation in the broadcast.<span style="mso-spacerun: yes">    
    </span></p>
  <p class=headingNUMBER style='line-height:normal'> [38]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The policy of the Act is to give media defendants an opportunity to 
    mitigate damages by apologizing or printing a retraction.<span
style="mso-spacerun: yes">  </span>Although Karisma and Amgen would not have been 
    in a position to make the decision as to whether or not a retraction would 
    be printed or an apology made, they were in a position to make best efforts 
    to cause retractions or apologies.<span style="mso-spacerun: yes">  </span>They 
    could also have purchased paid advertising and apologized for providing part 
    of the allegedly erroneous information that was broadcast.<span
style="mso-spacerun: yes">  </span>Therefore, the policy of the section supports 
    its application to Amgen and Karisma.<span style="mso-spacerun:
yes">    </span></p>
  <p class=headingNUMBER style='line-height:normal'> [39]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Furthermore, this court has reaffirmed <i>Watson</i> in <i>DeHeus 
    v. Niagara (Region) Police Services Board</i>, [2001] O.J. No. 4201,<i> Siddiqui 
    v. Canadian Broadcasting Corp. </i>(2000), 50 O.R. (3d) 607, and <i>Weiss 
    v. Sawyer</i> (2002), 61 O.R. (3d) 526, the latter of which was decided after 
    <i>Roach</i>, <i>supra</i>.<span style="mso-spacerun: yes">  </span>This is 
    not a situation of <i>per incuriam</i>.<span style="mso-spacerun: yes">  </span>See 
    <i
style='mso-bidi-font-style:normal'>Al’s Steakhouse &amp; Tavern Inc. v. Deloitte 
    &amp; Touche</i> (1997), 102 O.A.C. 144; (1997), 13 C.P.C. (4th) 90 (Ont. 
    C.A.).<span lang=EN-US style='mso-ansi-language:EN-US'><span
style="mso-spacerun: yes">  </span></span></p>
  <p class=headingNUMBER style='line-height:normal'> [40]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Without going into the jurisprudence that explains when a court can 
    depart from the values enshrined in the principle of <i>stare decisis</i> 
    it is enough to say that the discretion to overrule a prior decision must 
    be exercised in a principled manner.<span style="mso-spacerun: yes">  </span>In 
    this case, no principled reason has been shown to support exercising that 
    discretion.<span style="mso-spacerun: yes">  </span><span style='mso-bidi-font-style:
italic'>The </span>policy reasons for the notice requirement in s. 5(1) support 
    giving notice to these defendants.<span style="mso-spacerun: yes">  </span>Even 
    if the construction of s. 5(1) were modified as suggested by Professor Brown, 
    such that the notice requirement encompassed only persons alleged to have 
    responsibility for the appearance of the defamation in the broadcasts, the 
    notice requirements would still apply to Amgen and Karisma.<span
style="mso-spacerun: yes">  </span>Thus, overruling the <i>Watson</i> line of 
    cases would have no practical effect in this case.<span style="mso-spacerun:
yes">  </span>Any modification of the law would lead to the same result.<span
style="mso-spacerun: yes">  </span>I would hold that Janssen was required to deliver 
    a s. 5(1) defamation notice to Amgen and Karisma before starting litigation.</p>
  <h4 style='line-height:normal'><span lang=EN-US>2. Were the preconditions to 
    s. 5(1) met?</span></h4>
  <p class=headingNUMBER style='line-height:normal'> [41]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Sections 7 and 8 of the Act<i> </i>limit the application of the notice 
    requirement in s.&nbsp;5(1) to newspapers printed in and broadcasts made from 
    Ontario.<span style="mso-spacerun: yes">  </span>Janssen submits that the 
    motions judge did not make the necessary findings of fact to support the application 
    of s. 5(1) to the March broadcasts.<span style="mso-spacerun:
yes">  </span>In relation to the CFTR broadcast, there was no need for the motions 
    judge to make any finding of fact as the statement of claim pleads the CFTR 
    broadcast was from a station in Ontario.<span style="mso-spacerun: yes">  
    </span>Insofar as the Warren broadcast is concerned, again, there was no need 
    for her to make any finding of fact because the May&nbsp;15 notice purportedly 
    given pursuant to s. 5(1) indicates that one of the radio stations making 
    the broadcast is in Ontario.<span style="mso-spacerun: yes">  </span>The fact 
    that the broadcast was also made from other stations outside Ontario does 
    not matter: <i>Weiss</i>, <i>supra.</i><span style="mso-spacerun: yes">  </span>The 
    decision in <i>Weiss </i>also answers the submission that an Internet broadcast 
    is not a broadcast within the meaning of the Act. In <i>Weiss</i>,<i> supra</i>, 
    at paragraphs 24&#8209;26,<i> </i>the court held that the word “paper” was 
    broad enough to include a newspaper published on the Internet but left the 
    issue until another evidentiary record would allow the court to make a more 
    informed decision.<span style="mso-spacerun: yes">  </span>Similarly, the 
    definition of broadcasting is broad enough to include a broadcast over the 
    Internet.<span style="mso-spacerun: yes">  </span>In <i>Weiss</i>,<i> </i>the 
    original newspaper was published in Ontario.<span style="mso-spacerun: yes">  
    </span>The court did not discuss whether or not the online version was published 
    in Ontario.<span style="mso-spacerun: yes">  </span>However, the court held 
    that a s. 5(1) notice was required.<span style="mso-spacerun: yes">  </span>Thus, 
    it seems the court inferred the online version was also published in Ontario.<span style="mso-spacerun: yes">  
    </span>I would make the same inference here.<span style="mso-spacerun: yes">  
    </span>The same station that initiated the radio waves also initiated the 
    radio broadcast so it is a logical inference that the Internet broadcast was 
    also in Ontario.<span
style="mso-spacerun: yes">  </span></p>
  <p class=headingNUMBER style='line-height:normal'> [42]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Insofar as the e&#8209;mails are concerned, Amgen and Karisma concede 
    that the pleading in defamation can be sustained for the e&#8209;mails without 
    the requirement that notice be given under s. 5(1).<span
style="mso-spacerun: yes">  </span>They submit, however, that the pleading was 
    not based on the e&#8209;mails but rather on the subsequent March broadcasts.<span style="mso-spacerun: yes">  
    </span>I agree. They further submit that the e&#8209;mails caused no damage. 
    There may, however, be room for the application of rule 26.01 which provides:</p>
  <p class=Doubleindent-quote>On motion at any stage of an action the court shall 
    grant leave to amend a pleading on such terms as are just, unless prejudice 
    would result that could not be compensated for by costs or an adjournment.</p>
  <p class=ParaNO style='line-height:normal'>Following the release of this judgment, 
    Janssen may wish to move to amend its pleading to plead defamation and consequential 
    damages as a result of the e&#8209;mails.</p>
  <h4 style='line-height:normal'><span lang=EN-US>3. Did the April 2 statement 
    of claim comply with s. 5(1)?<i></i></span></h4>
  <p class=headingNUMBER style='line-height:normal'> [43]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The motions judge gave comprehensive reasons for her conclusion that 
    the April 2 statement of claim did not comply with s. 5(1) of the Act, holding 
    that notice was not delivered before the action was commenced.<span style="mso-spacerun: yes">  
    </span>She said:</p>
  <p class=Doubleindent-quote>There is considerable authority for the proposition 
    that failure to serve a section 5 notice is an absolute bar to a defamation 
    action: <i>Watson v. Southam</i>; <i>Grossman v. CFTO T.V. Ltd.</i>; <i>Frisina 
    v. Southam Press Ltd.</i>; <i>Elliott v. Friesen</i>; <i>Misir v. Toronto 
    Star Newspapers Ltd.,</i> <i>Siddiqui v. CBC</i>; <i>Merling v. Southam Inc.</i>; 
    and <i>Weiss v. Sawyer</i>.</p>
  <p class=Doubleindent-quote>There are two timing requirements. Firstly, the 
    notice must be served within six weeks of the alleged defamation and, secondly, 
    the notice must be served before an action is commenced: <i>Siddiqui v. CBC</i>. 
    As noted by Abella J.A. in that case, “The fact that the notice was served 
    within six weeks of the alleged libel is only one-half of the timing requirements 
    for service of the written notice; the other mandatory requirement, which 
    was not satisfied in this case, is that the notice be served before an action 
    is commenced.” </p>
  <p class=Doubleindent-quote>While proof of facts is not permitted on such a 
    motion, as requested by Ms. Podrebarac on behalf of Janssen, I am prepared 
    to consider the qualification made to the admission as set out in counsel’s 
    correspondence of May 28, 2003. It is clear from that qualification that the 
    original statement of claim and the motion record for the injunctive relief 
    constituted the first notice to Amgen of Janssen’s intent to sue for defamation 
    with respect to the two subject broadcasts. No prior notice was provided. 
    As noted by Abella J.A. in <i>Watson v. Southam Inc.</i>, the discoverability 
    principle applies to section 5 of the <i>Libel and Slander Act</i> but this 
    is only of assistance with respect to meeting the six week timing requirement.<span style="mso-spacerun: yes">  
    </span>Janssen was still required to meet the second requirement that notice 
    must be served before an action is commenced. Notice enables the alleged offender 
    to mitigate damages. It cannot be said that the original statement of claim 
    constituted notice. Such a conclusion would neutralize the meaning and objective 
    of section 5 as reflected in the case law. In this regard, see also <i>Stuarts 
    Furniture &amp; Appliances v. No Frills Appliances and TV Ltd</i>. Furthermore, 
    the motion record on its own could not constitute prior notice as, given its 
    action number, it is obvious that it was not served before the original statement 
    of claim was issued. I do not accept Janssen’s position that the law on whether 
    notice is required in the circumstances of non-media defendants is unsettled. 
    Although there may be legitimate criticism of the state of the law, it cannot 
    be said that it is unsettled. The decision of the Court of Appeal in <i>Roach 
    v. Now Communications Inc.</i> did not overrule <i>Watson v. Southam Inc.</i></p>
  <p class=headingNUMBER style='line-height:normal'> [44]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> I agree with and adopt her analysis.<span style="mso-spacerun:
yes">  </span>The motions judge’s reference to <i>Stuarts Furniture &amp; Appliances 
    v. No Frills Appliances &amp; T.V. Ltd.</i> (1982), 40 O.R. (2d) 52 is apt. 
    At 53, this Court stated, “[i]t is not a reasonable view of what the legislation 
    contemplates to say that the alleged wrongdoer has every opportunity to apologize 
    in the midst of litigation after receipt of the statement of claim”.</p>
  <p class=headingNUMBER style='line-height:normal'> [45]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> As did the motions judge, I would reject Janssen’s submission that 
    the motion record for injunctive relief served on Amgen and Karisma constituted 
    notice under s. 5(1) in relation to the April 2 statement of claim.<span style="mso-spacerun: yes">  
    </span>As she noted, the number on the motion record indicated it was served 
    after the statement of claim was issued. Secondly, Janssen’s request for injunctive 
    relief did not excuse it from complying with the requirement to serve a defamation 
    notice.<span style="mso-spacerun:
yes">  </span>Thirdly, as I have said, the law is settled on the issue of whether 
    non-media defendants are entitled to receive notice under s. 5(1) of the Act.<i><span style="mso-spacerun: yes">  
    </span></i>Fourthly, although the discoverability rule applies, the submission 
    that Janssen only discovered that the defendants were responsible for the 
    broadcasts when it received Karisma’s statement of defence and affidavit is 
    disingenuous in light of its April 2 statement of claim against Amgen and 
    Karisma. Therefore, the motions judge correctly held that no s. 5(1) notice 
    was delivered with respect to the March broadcasts.</p>
  <h4 style='line-height:normal'><span lang=EN-US>4. Was the motions judge entitled 
    to strike the April 2 claim against Amgen on the basis of rule 51.06?</span></h4>
  <p class=headingNUMBER style='line-height:normal'> [46]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The motions judge began this portion of her reasons by setting out 
    the principles applicable on a motion for an order based on an admission as 
    set out in <i>Sigroum v. Milanis</i> (1985), 4 C.P.C. (2d) 243.<span
style="mso-spacerun: yes">  </span>She considered the qualification made to the 
    admission by counsel for Janssen in correspondence dated May 28, 2003. As 
    I have indicated above, she rejected the submission that the law was unsettled 
    and held there was considerable authority for the proposition that failure 
    to serve a s. 5(1) notice under the Act is an absolute bar to a defamation 
    action.<span style="mso-spacerun: yes">  </span>She concluded that Amgen should 
    succeed on the admission as it related to the defamation claims arising out 
    of the subject matter of the two broadcasts.<span style="mso-spacerun: yes">  
    </span></p>
  <p class=headingNUMBER style='line-height:normal'> [47]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Rule 51.06(1) deals with admissions.<span style="mso-spacerun:
yes">  </span>It states: </p>
  <p class=Doubleindent-quote>Where an admission of the truth of a fact or the 
    authenticity of a document is made, </p>
  <p class=Double-indent-subquote>(a)<span
style='mso-tab-count:1'> </span>in an affidavit filed by a party,</p>
  <p class=Double-indent-subquote>(b)<span
style='mso-tab-count:1'> </span>in the examination for discovery of a party or 
    a person examined for discovery on behalf of a party; or</p>
  <p class=Double-indent-subquote>(c)<span
style='mso-tab-count:1'> </span>by a party on any other examination under oath 
    or affirmation in or out of court,</p>
  <p class=Doubleindent-quote>any party may make a motion to a judge in the same 
    or another proceeding for such order as the party may be entitled to on the 
    admission without waiting for the determination of any other question between 
    the parties, and the judge may make such order as is just.</p>
  <p class=headingNUMBER style='line-height:normal'> [48]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In its Notice of Motion, Amgen stated:</p>
  <p class=Doubleindent-quote>The Plaintiff <i>has admitted</i> in this proceeding 
    that it did not provide a notice regarding the allegations of defamation contained 
    in paragraphs 26 to 32 of the <u>Amended</u> Statement of Claim as required 
    under section 5 of the <i>Libel and Slander Act.</i></p>
  <p class=headingNUMBER style='line-height:normal'> [49]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In oral argument before us, Janssen submitted that the motions judge 
    was not entitled to strike the April 2 claim in relation to Amgen because 
    Amgen did not rely on rule&nbsp;51.06 in its notice of motion, relying instead 
    on rule 56.01.<span style="mso-spacerun: yes">  </span>Although the Notice 
    of Motion did not specifically refer to rule 51.06(1), as required by rule 
    37.06(b), the admission was clearly set out as a ground to be argued and it 
    is apparent from the motions judge’s reasons that argument was made in respect 
    to it.<span style="mso-spacerun: yes">  </span>Janssen was not prejudiced 
    by Amgen’s omission to specify the rule.<span style="mso-spacerun: yes">   
    </span>In the circumstances, the failure to refer to rule 51.06(1) in Amgen’s 
    Notice of Motion was an irregularity that had no effect and can be cured by 
    the application of rule 2.01.<span style="mso-spacerun: yes">  </span>The 
    motions judge was entitled to consider rule 51.06(1) in deciding the motions.</p>
  <p class=headingNUMBER style='line-height:normal'> [50]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Janssen further submits that the admission made was not clear and 
    definite as required by <i>Sigroum v. Milanis</i>, <i>supra</i>, but was rather 
    a qualified, limited admission.<span style="mso-spacerun: yes">  </span>Therefore, 
    it argues that the motions judge erred in her application of rule 51.06(1).<span style="mso-spacerun: yes">  
    </span>The admission that Janssen had not delivered a s. 5(1) notice prior 
    to issuing the April 2 statement of claim was clear and definite.<span style="mso-spacerun: yes">  
    </span>The subsequent letter on May 15 sought to bring in the discoverability 
    rule and purported to give notice pursuant to s. 5(1).<span
style="mso-spacerun: yes">  </span>Implicitly, therefore, the May 15 letter confirmed 
    the admission that no notice was given prior to the April 2 statement of claim.<span style="mso-spacerun: yes">  
    </span>The discoverability argument was itself contradicted by the prior statement 
    of claim.<span
style="mso-spacerun: yes">  </span>The May 28 letter stated that the motion record 
    for the injunction constituted notice of the April 2 claim.<span
style="mso-spacerun: yes">  </span>The letter raised an argument in law that was 
    rejected.<span style="mso-spacerun: yes">  </span>The admission remained clear 
    and unambiguous.<span style="mso-spacerun: yes">  </span>The motions judge 
    correctly applied the requirements of <i>Sigroum v. Milanis</i>, <i>supra</i>.<span
style="mso-spacerun: yes">  </span>The wording of the rule is broad enough to 
    allow a judge to strike pleadings. The motions judge was entitled to make 
    the order she did in relation to the March broadcasts pursuant to rule 51.06(1).<span style="mso-spacerun: yes">  
    </span></p>
  <h4 style='line-height:normal'><span
lang=EN-US>5. Did the motions judge err in holding that Karisma could not rely 
    on rule 51.06?</span></h4>
  <p class=headingNUMBER style='line-height:normal'> [51]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The motions judge held:</p>
  <p class=Doubleindent-quote>No paragraph [alleging defamation] is struck out 
    as against Karisma pursuant to this Rule as no admission under oath on an 
    examination was made with respect to this party as required by Rule 51.06(1)(c).<span style="mso-spacerun: yes">  
    </span>Rule 51.06(2) requires an admission “in the same proceeding” and there 
    was no admission relating to Karisma in the first action.</p>
  <p class=headingNUMBER style='line-height:normal'> [52]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Karisma submits that the motions judge erred in failing to strike 
    the defamation claim against it under rule 51.06(1).<span
style="mso-spacerun: yes">  </span>Janssen’s position is that although it wrote 
    letters to Karisma containing an admission, the only admission made under 
    oath was made during Amgen’s cross-examination of Dr. Arnott.<span
style="mso-spacerun: yes">  </span>Thus, Janssen submits that no admission under 
    oath was made to Karisma and any admission was not made in the same proceeding 
    as the defamation action against Karisma. </p>
  <p class=headingNUMBER style='line-height:normal'> [53]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Rule 51.06(1) provides that, on admission by a party on any examination 
    under oath, “<i>any</i> party may make a motion to a judge <i>in the same 
    or another proceeding</i> for such order as the party may be entitled to on 
    the admission” (emphasis added).<span style="mso-spacerun: yes">  </span>Therefore, 
    Karisma can rely on the admission made to Amgen.</p>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-style:italic'>[54]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Quite apart from the wording of the rule, it would be wasteful 
    for each individual party to have to ask the same questions in cross&#8209;examination 
    of a deponent and obtain the same answers in order for the admission to bind 
    the party on whose behalf the deponent was examined: see by analogy <i>Place 
    Concorde East Ltd. Partnership v. Shelter Corp. of Canada Ltd.</i>, [1999] 
    CarswellOnt 2422, <i>per</i> Farley J. at para 5.<span style="mso-spacerun:
yes">  </span>This practical consideration <span lang=EN-US style='color:black;
mso-ansi-language:EN-US'>supports the interpretation of the words “any party” 
    that I have adopted. </span><i></i></p>
  <p class=headingNUMBER style='line-height:normal'> [55]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Rule 51.06(2), mentioned by the motions judge as the basis for refusing 
    to grant judgment based on the admission in favour of Karisma, does not apply 
    here.<span style="mso-spacerun: yes">  </span>Rule 51.06(2) limits motions 
    for judgment to the same proceeding where the admission is made in pleadings 
    or pursuant to a request to admit.<span style="mso-spacerun: yes">  </span>Here 
    the admission was not made in the pleading that comprised the April 2 statement 
    of claim and there has been no request to admit.<span
style="mso-spacerun: yes">  </span>Instead, the admission of Dr. Arnott, a vice&#8209;president 
    of Janssen, was made during cross-examination on her affidavit and the applicable 
    rule is 51.06(1)(c), which allows judgment in the same or <i>another</i> proceeding.<span style="mso-spacerun: yes">  
    </span>Therefore, the motions judge erred in holding that Karisma was not 
    entitled to rely on Dr. Arnott’s admission to Amgen. Karisma was equally entitled 
    to have the April 2 pleading in defamation respecting the March broadcasts 
    struck against it based on the admission.</p>
  <h4 style='line-height:normal'><span lang=EN-US>6. Was the motions judge entitled 
    to strike the April 2 claim against Karisma on the basis of rule 21.01(1)(a)?</span></h4>
  <p class=headingNUMBER style='line-height:normal'> [56]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Rule 21.01(1)(a) states:</p>
  <p class=Doubleindent-quote>A party may move before a judge,</p>
  <p class=Double-indent-subquote>(a) for the determination, before trial, of 
    a question of law raised by a pleading in an action where the determination 
    of the question may dispose of all or part of the action, substantially shorten 
    the trial or result in a<span style="mso-spacerun: yes">  </span>substantial 
    saving of costs;</p>
  <p class=Doubleindent-quote align=center style='text-align:center'><b><span
lang=EN style='mso-ansi-language:EN'>. . .</span></b></p>
  <p class=Doubleindent-quote><span lang=EN
style='mso-ansi-language:EN'>and a judge may make an order or grant judgment accordingly.</span></p>
  <p class=headingNUMBER style='line-height:normal'> [57]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The motions judge first considered whether to grant leave to consider 
    evidence on the motion under rule<i> </i>21.01(2), which states: </p>
  <p class=Doubleindent-quote>21.01(2)<span
style='mso-tab-count:1'> </span>No evidence is admissible on a motion,</p>
  <p class=Doubleindent-quote>(a)<span style='mso-tab-count:1'> </span>under clause 
    (1)(a) except with leave of a judge or on consent of the parties</p>
  <p class=Doubleindent-quote>(b)<span
style='mso-tab-count:1'> </span>under clause (1)(b)</p>
  <p class=headingNUMBER style='line-height:normal'> [58]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The motions judge concluded that it was appropriate to grant leave 
    to consider “all of this evidence”, namely, Dr. Arnott’s cross-examination, 
    the second statement of claim, and Janssen’s reply to Amgen’s demand for particulars.<span style="mso-spacerun: yes">  
    </span>She held that Karisma should succeed in its motion under rule 21.01(1)(a).</p>
  <p class=headingNUMBER style='line-height:normal'> [59]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Given my conclusion that Karisma could also have relied on the admission 
    made to Amgen, it is not strictly speaking necessary to decide whether the 
    motions judge was entitled to strike Karisma’s pleading on the basis of rule 
    21.01(1)(a).<span style="mso-spacerun: yes">  </span>On the other hand, having 
    regard to the attention the parties gave to this issue and the likelihood 
    of the issue arising again, I propose to express my view.</p>
  <p class=headingNUMBER style='line-height:normal'> [60]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In <i>Beardsley v. Ontario </i>(2001), 57 O.R. (3d) 1 (C.A.), this 
    court held that where notice is a necessary precondition to the right to sue, 
    it would defeat the interests of justice to restrict the defendant’s right 
    to adduce evidence that notice was not given.<span style="mso-spacerun: yes">  
    </span>In that case,<i> </i>the plaintiff issued a claim against the Crown 
    and two police officers.<span style="mso-spacerun: yes">  </span>The defendants 
    moved to strike the claim <i>before</i> filing a defence.<span
style="mso-spacerun: yes">  </span>The Crown moved on the basis that no notice 
    had been provided pursuant to s. 7(1) of the <i>Proceedings Against the Crown 
    Act</i>, R.S.O. 1990, c. P.27 (“<i>PACA</i>”).<span style="mso-spacerun: yes">  
    </span>Section 7 states, “no action for a claim shall be commenced against 
    the Crown unless the claimant has, at least sixty days before the commencement 
    of the action, served on the Crown a notice of claim”.<span style="mso-spacerun:
yes">  </span>The Crown sought leave to rely on a formal notice letter sent by 
    the plaintiff the day <i>after </i>the statement of claim was issued to assert 
    that the notice requirement had not been complied with.<span
style="mso-spacerun: yes">  </span></p>
  <p class=headingNUMBER style='line-height:normal'> [61]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> This court ruled that the formal notice letter was properly admitted 
    pursuant to the discretion contained in rule 21.01(2) to permit evidence on 
    a motion under rule<i>&nbsp;</i>21.01(1)(a).<span
style="mso-spacerun: yes">  </span>In addition, the Court held that service of 
    the formal notice letter <i>after the action was commenced</i> could not satisfy 
    the notice requirement in s. 7.<i> </i><span style="mso-spacerun:
yes"> </span>It dismissed the plaintiff’s claim against the Crown.<span
style="mso-spacerun: yes">  </span>However, this Court refused to strike the claim 
    against the two officers on the basis of the expiry of the limitation period 
    under s. 7(1).<span style="mso-spacerun: yes">  </span>The Court ruled that 
    the expiry of a limitation period, unlike the failure to give notice, does 
    not render a cause of action a nullity.<span style="mso-spacerun: yes">  </span>Rather, 
    it is a defence that must be pleaded.<span style="mso-spacerun:
yes">  </span>Hence, no defence having been filed, the claim could not be struck 
    at the rule&nbsp;21.01(1)(a) stage.</p>
  <p class=headingNUMBER style='line-height:normal'> [62]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Section 5(1) of the Act is similar to s. 7 of <i>PACA</i>.<span
style="mso-spacerun: yes">  </span>It states that “[<i>n</i>]<i>o action</i> for 
    libel in a newspaper or in a broadcast lies<i> unless</i> the plaintiff has, 
    within six weeks after the alleged libel has come to the plaintiff’s knowledge, 
    given to the defendant notice in writing, specifying the matter complained 
    of” (emphasis added).<span style="mso-spacerun: yes">  </span>As was the case 
    with the plaintiff in <i>Beardsley</i>,<i> </i>Karisma alleges notice was 
    provided after the commencement of the litigation.</p>
  <p class=headingNUMBER style='line-height:normal'> [63]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Janssen argues that Karisma had to file a statement of defence pleading 
    that notice had not been given.<span style="mso-spacerun: yes">  </span>Janssen 
    relies on <i>Canadian Plasmapheresis Centres Ltd. v. Canadian Broadcasting 
    Corp. et al.</i> (1975), 8 O.R. (2d) 55 (H.C.).<span
style="mso-spacerun: yes">  </span>In that case, Lieff&nbsp;J. stated that the 
    s. 5(1) notice was a condition precedent that the plaintiff did not need to 
    plead and that the defendant’s motion under Rule 124 to decide a point of 
    law was “premature”.<span style="mso-spacerun: yes">  </span>The present rule 
    is the same in substance as Rule 124: Holmested and Watson, <i>Ontario Civil 
    Procedure</i>, vol. 3 (Toronto: Carswell, 2004) at 25-28.<span
style="mso-spacerun: yes">  </span><i>Plasmapheresis</i> has been followed in 
    several Ontario cases that required the defendant to plead the failure to 
    provide notice: see <i>Robinson v. Club Epiphany Restaurant &amp; Lounge</i>, 
    [2001] O.J. No. 2101 (Sup. Ct.) Epstein J. at para. 9; <i>Greater Toronto 
    Airports Authority v. Air Canada</i>, [1999] O.J. No. 2532.</p>
  <p class=headingNUMBER style='line-height:normal'> [64]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The court in <i>Beardsley</i> did not refer to <i>Plasmapheresis</i> 
    nor did it refer to the presumption in rule 25.06(3), which states: </p>
  <p class=Doubleindent-quote>Allegations of the performance or occurrence of 
    all conditions precedent to the assertion of a claim or defence of a party 
    are implied in the party’s pleading and need not be set out, and an opposite 
    party who intends to contest the performance or occurrence of a condition 
    precedent shall specify in the opposite party’s pleading the condition and 
    its non-performance or non-occurrence.</p>
  <p class=headingNUMBER style='line-height:normal'> [65]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Another potentially relevant rule is rule 25.06(6), which deals specifically 
    with notice.<span style="mso-spacerun: yes">  </span>It states, “Where notice 
    to a person is alleged, it is sufficient to allege notice as a fact unless 
    the form or a precise term of the notice is material”. </p>
  <p class=headingNUMBER style='line-height:normal'> [66]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Rule 25.06(6) does not, however, specify <i>when</i> notice must be 
    alleged.<span style="mso-spacerun: yes">  </span>In relation to pleading conditions 
    precedent Holmested and Watson state at 25-28 that:</p>
  <p class=Doubleindent-quote>By reason of rule 25.06(3) (condition precedent), 
    there will usually be no obligation on the plaintiff to plead the giving of 
    notice – it will be implied in the statement of claim.<span style="mso-spacerun: yes">  
    </span>If the defendant wishes to contest that notice was given, he or she 
    will have to specifically so plead in his or her defence.</p>
  <p class=headingNUMBER style='line-height:normal'> [67]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The final rule that may have relevance is rule 1.04(1), which states, 
    “These rules shall be liberally construed to secure the just, most expeditious 
    and least expensive determination of every civil proceeding on its merits”.</p>
  <p class=headingNUMBER style='line-height:normal'> [68]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Both <i>Plasmapheresis </i>and <i>Beardsley</i> must be considered 
    in this context and in the context of their own facts.<span
style="mso-spacerun: yes">  </span>In <i>Plasmapheresis</i>,<i> </i>the court 
    had before it only the statement of claim on the motion to determine an issue 
    before trial.<span style="mso-spacerun: yes">  </span>The court held that 
    the equivalent to what is now rule 25.06(3) – Rule 148 – meant that the motion 
    was premature.<span style="mso-spacerun: yes">  </span>In so doing, the court 
    considered other decisions in which similar motions had been brought and noted 
    that in those cases the pleadings were complete.<span style="mso-spacerun:
yes">  </span>In one of them – <i>Trottier v. John Blunt Publications, Ltd. et 
    al.</i>, [1950] O.W.N. 678 – Gale J. refused to exercise his discretion to 
    admit evidence obtained upon the cross-examination of the plaintiff, opining 
    that the rule contemplated a decision on a point of law raised by the pleadings 
    and that it was improper to look at evidence found in extraneous documents. 
    <i><span
style="mso-spacerun: yes"> </span></i>Since the decision in <i>Trottier</i>, referred 
    to by Lieff J. in <i>Plasmapheresis</i>, judges sometimes exercise their discretion 
    to admit evidence.<span style="mso-spacerun: yes">  </span>This court held 
    that evidence of a formal notice letter delivered after the statement of claim 
    was properly admitted as evidence under rule 21.01(1)(a) in <i>Beardsley</i>.<span style="mso-spacerun: yes">  
    </span></p>
  <p class=headingNUMBER style='line-height:normal'> [69]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In <i>Roach</i>, <i>supra</i>, on appeal, but not before the motion 
    judge, the appellant relied on <i>Plasmapheresis</i> and contended that a 
    motion to strike a claim based on the failure to serve a s. 5(1) notice was 
    premature because a statement of defence had not been filed.<span
style="mso-spacerun: yes">  </span>Doherty J.A. commented that there was “considerable 
    merit to this submission”.<span style="mso-spacerun: yes">  </span>Noting 
    that it had not been raised before the motion judge, he concluded, “Nothing 
    would be gained by requiring Mr. Davis to recommence this motion after service 
    of his statement of defence”.<span style="mso-spacerun:
yes">  </span>In that case, Doherty J.A. held that the defamation notice was properly 
    served and set aside the order striking the statement of claim.</p>
  <p class=headingNUMBER style='line-height:normal'> [70]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> From the foregoing I deduce the following principles.<span
style="mso-spacerun: yes">  </span>First, where notice is a precondition to the 
    commencement of an action, the statement of claim need not contain a pleading 
    that notice was given prior to the commencement of the action (rule 25.06(3)).<span style="mso-spacerun: yes">  
    </span>Second, defendants generally should file a statement of defence pleading 
    non-compliance with a precondition (rule 25.06(3)).<span style="mso-spacerun: yes">  
    </span>Third, if the defendant tenders evidence that clearly shows that a 
    precondition has not been met, thereby rebutting the presumption of compliance 
    in rule 25.06(3), and the motion judge admits the evidence under rule 21.01(2) 
    because it would be pointless to require the defendant to file a statement 
    of defence before moving for summary judgment or an order under Rule 21, an 
    appellate court will not interfere with the motion judge’s exercise of discretion.</p>
  <p class=headingNUMBER style='line-height:normal'> [71]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In the case before us, the motions judge exercised her discretion 
    to admit evidence that clearly rebutted the presumption in rule 25.06(3).<span style="mso-spacerun: yes">  
    </span>Accordingly she did not err in granting judgment to Karisma with respect 
    to the March broadcasts.</p>
  <p class=headingNUMBER style='line-height:normal'> [72]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Janssen also submitted that the requirement to give notice under s. 
    5(1) was akin to a limitation period and not a precondition.<span
style="mso-spacerun: yes">  </span>The Supreme Court determined that issue in 
    <i>Sentinel-Review Co. Ltd. v. Robinson et al.</i>, [1928] S.C.R. 258, holding 
    that the notice required under the Act is a condition precedent and not a 
    defence.</p>
  <h4 style='line-height:normal'><span lang=EN-US>7. Did the motions judge err 
    in striking out the references in Janssen’s claim for defamation to the comments 
    made by Member of Parliament Svend Robinson?</span></h4>
  <p class=headingNUMBER style='line-height:normal'> [73]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The motions judge held:</p>
  <p class=Doubleindent-quote>In my view, the fact that the statements made in 
    Parliament do not form the basis of Janssen’s defamation claims but support 
    its other various claims is immaterial.<span
style="mso-spacerun: yes">  </span>The court may not inquire into the statements 
    that are the subject matter of paragraph 33 of the amended statement of claim 
    as they are protected by absolute privilege.<span style="mso-spacerun:
yes">  </span>Accordingly, paragraph 33 is struck both pursuant to Rule 21.01(1)(a) 
    and Rule 25.11(b) and (c).</p>
  <p class=ParaNO style='line-height:normal'>She also struck the corresponding 
    paragraphs in the June 12 statement of claim.</p>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-style:italic'>[74]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> In coming to her conclusion that the statements made in the 
    House of Commons were privileged, the motions judge relied on <i>Stopforth 
    v. Goyer</i> (1979), 23 O.R. (2d) 696 (C.A.)<i> </i>and<i> Roman Corp. Ltd. 
    v. Hudson’s Bay Oil and Gas Co. Ltd.</i>, [1971] 2 O.R. 418 (H.C.J.), aff’d 
    [1972] 1 O.R. 444 (C.A.), aff’d [1973] S.C.R. 830,<i> </i>which adopted and 
    followed the earlier decision of <i>Church of Scientology of California v. 
    Johnson-Smith</i>, [1972] 1 Q.B. 522.<span style="mso-spacerun: yes">  </span>The 
    appellant submits that the decisions on which the motions judge relied can 
    be distinguished because the defamation actions in those cases were brought 
    against the members of the House whereas here it is not.<span
style="mso-spacerun: yes">  </span><i></i></p>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-style:italic'>[75]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> The Appellant invokes the Australian case of <i>Mundey v. Askin</i>, 
    [1982] 2 N.S.W.L.R. 369 (C.A.)<i> </i>as support for its position that statements 
    made in the House of Commons may be relied on to prove the fact that certain 
    things were said in Parliament, thereby supporting a cause of action for defamation.<span style="mso-spacerun: yes">  
    </span>However, in <i>Mundey</i> the Court cited <i>Church of Scientology 
    </i>as an accurate statement of the law.<span style="mso-spacerun: yes">  
    </span>It also noted that the question it faced did not relate to the motives 
    of a parliamentarian, but only to the admissibility of evidence, and thus 
    did not offend against the absolute privilege.<i></i></p>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-style:italic'>[76]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> In the recent decision of <i>Canada (House of Commons) v.</i> 
    <i>Vaid</i>,<i> </i>2005 S.C.C. 30, Binnie J. reviewed and summarized the 
    principles relating to parliamentary privilege.<span style="mso-spacerun:
yes">  </span>In doing so, he stated that the existence and scope of an inherent 
    privilege is to be determined by asking whether the claimed privilege has 
    been authoritatively established.<span style="mso-spacerun: yes">  </span>If 
    not, in order to sustain a claim of privilege it must be shown that the sphere 
    of activity for which privilege is claimed is so closely and directly connected 
    with the fulfilment of the member’s functions, including holding the government 
    to account, that outside interference would undermine the extent of the autonomy 
    required by the member to do his or her work with dignity and efficiency.<span style="mso-spacerun: yes">  
    </span><i></i></p>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-style:italic'>[77]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> In the present case, Janssen alleges that the defendants caused 
    the Member of the House to make statements in the House that were defamatory.<span style="mso-spacerun: yes">  
    </span>Hence, what caused the<span style="mso-spacerun: yes">   </span>Member 
    of the House to make the statement would be necessarily implicated in the 
    litigation.<span
style="mso-spacerun: yes">  </span><i></i></p>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-style:italic'>[78]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Freedom of speech within the House is a well-recognized category 
    of parliamentary privilege. Further, the Member was engaged in the work of 
    a legislator, calling the government to account, when he asked his question. 
    What motivated the Member to make the statement is precisely what cannot be 
    examined in the context of a civil action for defamation because it would 
    undermine the level of autonomy required to enable the Member to do his work 
    properly. Quite apart from the potential interference in internal matters 
    of the House that such external intervention would cause, it would inevitably 
    create delay, disruption, and uncertainty. No doubt there are cases in which 
    it would not be possible at this stage to see clearly whether words spoken 
    are privileged but this is not such a case.<span style="mso-spacerun: yes">  
    </span>It follows that the motions judge was correct in striking Janssen’s 
    claim for defamation arising from the statements in the House.<i></i></p>
  <h4 style='line-height:normal'><span
lang=EN-US>B.<span style='mso-tab-count:1'>      </span>The Cross-Appeal by Amgen 
    and Karisma</span></h4>
  <p class=headingNUMBER style='line-height:normal'> [79]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> The motions judge refused to dismiss the second action commenced June 
    12 pursuant to rule 21.01(3)(c) as being a multiplicity of proceedings because 
    she struck the similar claims in the April 2 statement of claim.<span style="mso-spacerun: yes">  
    </span>She refused to dismiss the June 12 action pursuant to rule 21.01(3)(d) 
    as being frivolous, vexatious, or an abuse of process holding that, “the substantive 
    issues in dispute between the parties should not be defeated on essentially 
    procedural grounds”. </p>
  <p class=headingNUMBER style='line-height:normal'> [80]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Ground J. refused to grant leave to Amgen and Karisma to appeal the 
    motions judge’s refusal to dismiss the June 12 defamation action.<span style="mso-spacerun: yes">  
    </span>Before us, Amgen and Karisma submit that leave is not necessary because 
    the motions judge’s refusal to dismiss the action is a final order.<span style="mso-spacerun: yes">   
    </span></p>
  <p class=headingNUMBER style='line-height:normal'> [81]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> In view of my conclusion below on the appeal transferred from the 
    Divisional Court, it is not necessary to resolve the preliminary issue of 
    whether the order was a final order.<span style="mso-spacerun: yes">  </span>Accordingly, 
    I would make no order on the cross-appeal.</p>
  <h4 style='line-height:normal'><span
lang=EN-US>C.<span style='mso-tab-count:1'>       </span>The Appeal Transferred 
    from the Divisional Court</span></h4>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>[82]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> The issue to be decided on this appeal is whether the motions 
    judge erred in refusing to strike certain paragraphs alleging defamation in 
    the June 12 statement of claim under rule&nbsp;21.01(1)(b) as disclosing no 
    cause of action.<b><i></i></b></p>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>[83]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> In refusing to strike these paragraphs the motions judge held:<b><i></i></b></p>
  <p class=Doubleindent-quote>In this second action, it is not plain and obvious 
    that no section 5 notice was provided to the defendants.<span style="mso-spacerun: yes">  
    </span>It is at least arguable that the defendants were served with notice 
    of the claims in the particular circumstances of this case. It is not plain 
    and obvious that the statement of claim discloses no reasonable cause of action. 
  </p>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>[84]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Although a precondition need not be pleaded, the June 12 statement 
    of claim alleged that notice of the defamation was given on April 2 and subsequent 
    dates.<span style="mso-spacerun: yes">  </span>Unless notice of the radio 
    broadcasts was given on April 2, the s.&nbsp;5(1) notice requirement was not 
    met.<span style="mso-spacerun: yes">  </span>Janssen submits that as no evidence 
    is admissible on a motion under rule&nbsp;21.01(1)(b) the pleading of notice 
    in the June 12 statement of claim must be accepted on its face.<b><i></i></b></p>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>[85]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Before the panel heard argument on this issue, Janssen raised 
    a preliminary point.<span style="mso-spacerun: yes">  </span>It submitted 
    that tabs 11 to 17 of Amgen and Karisma’s appeal book were improper.<span style="mso-spacerun: yes">  
    </span>Janssen’s position is that the “evidence” at these tabs was not properly 
    before the court and, prior to the hearing of this appeal, it brought a motion 
    to that effect which was reserved to the full panel. <b><i></i></b></p>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>[86]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Tab 11 is Amgen’s demand for particulars dated September 15, 
    2003; tab 12 is Janssen’s reply to the demand dated January 12, 2004, that, 
    for ease of reference, I have reproduced below:<span
style="mso-spacerun: yes">   </span><b><i></i></b></p>
  <p class=Doubleindent-quote>[N]otice in writing specifying the matters complained 
    of as prescribed by Section 5 of the <i>Libel and Slander Act </i>was served 
    personally on each of the Defendants on April 2, 2003, in the form of the 
    Plaintiff’s Motion Record in support of an interim, interlocutory and permanent 
    injunction, which was served at the same time as the Statement of Claim.<span style="mso-spacerun: yes">  
    </span>Full particulars of the matters complained of are set out in paragraphs 
    36 to 43 of Dr. Arnott’s above referenced Affidavit (and exhibits K, L and 
    M thereto), which was at Tab 2 of the Plaintiff’s Motion Record.<span style="mso-spacerun:
yes">  </span></p>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-weight:bold'>[87]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Tabs 13-16 of the Appeal Book consist of the injunction motion 
    record dated April&nbsp;2, 2003, excerpts from the cross-examination of Dr.&nbsp;Wendy 
    Arnott dated April 29, 2003, and correspondence from Janssen’s counsel dated 
    May 28 and August 25, 2003.</p>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-weight:bold'>[88]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Janssen’s position is that the demand for particulars, the 
    reply, and all of the material referred to in the reply is evidence that cannot 
    be considered on a rule&nbsp;21.01(1)(b) motion.<span
style="mso-spacerun: yes">  </span></p>
  <p class=headingNUMBER style='line-height:normal'> <span
lang=EN-US style='mso-ansi-language:EN-US'>[89]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Janssen’s argument requires this court to consider the effect 
    of particulars.<span style="mso-spacerun: yes">  </span>Particulars<span
lang=EN-US style='mso-ansi-language:EN-US'> are not evidence.<span
style="mso-spacerun: yes">  </span>As Master Sandler stated in the often-cited 
    <i>Copland v. Commodore Business Machines Ltd.</i> (1985), 52 O.R. (2d) 586:</span></p>
  <p class=Doubleindent-quote>Material facts must be pleaded; evidence must not 
    be pleaded. In between the concept of “material facts” and the concept of 
    “evidence”, is the concept of “particulars”. These are additional bits of 
    information, or data, or detail, that flesh out the “material facts”, but 
    they are not so detailed as to amount to “evidence”. </p>
  <p class=headingNUMBER style='line-height:normal'> [90]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Particulars become part of the pleadings; they are not evidence: Raymond 
    E. Brown, <i>The Law of Defamation in Canada</i> looseleaf vol. 3, 2d ed. 
    (Toronto: Carswell, 2004) at 20.2 (“Since the particulars, when furnished, 
    become part of the pleadings, the party delivering them may be confined at 
    discovery, or at trial, to the matters given in the particulars” citing <i>Rotstein 
    v. Globe &amp; Mail (The)</i> (1997), 18 C.P.C. (4th) 144 (Ont. Master)); 
    <i>Owen Sound Lumber Co. v. Seaman Kent Co. </i>(1913), 5 O.W.N. 93 at 94 
    (particulars are “supplementary to the pleadings, in fact, as an amendment 
    to pleadings embarrassing by reason of lack of particularity”).</p>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-weight:bold'>[91]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Brown states at 20-4, “Particulars are particularly important 
    in a cause of action as technical and complex as that of defamation”.<span style="mso-spacerun: yes">  
    </span>Further at 20-8 Brown states:</p>
  <p class=Doubleindent-quote>If it is sufficiently clear that the particulars 
    supplied by the plaintiff will not entitle him to get his case to the jury, 
    the defendant may rely on those particulars to support an application to stay 
    the action or strike out the pleadings.</p>
  <p class=ParaNO style='line-height:normal'>For this proposition, Professor Brown 
    cites <i>Searle v. Mirror Newspapers Ltd.</i>, [1974] 1 N.S.W.L.R. 180 (C.A.), 
    which was followed in <i>Krahne v. T.C.N. Channel Nine Pty. Ltd.</i>, [1986] 
    4 N.S.W.L.R. 536.</p>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-weight:bold'>[92]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Janssen’s submission ignores the particulars that were furnished 
    respecting the allegation in its statement of claim.<span
style="mso-spacerun: yes">  </span>The particulars provided narrowed the scope 
    of the statement of claim. Because particulars are not evidence, on a motion 
    under rule&nbsp;21.01(1)(b) the motions judge was entitled to consider as 
    having been pleaded the fact that the alleged notice given on April 2 was 
    in the form of the motion record in support of the injunction served at the 
    same time as the statement of claim.<span style="mso-spacerun: yes">  </span>This 
    information was contained in the first sentence of the particulars.<span
style="mso-spacerun: yes">  </span>It is not necessary to rely on the information 
    in tabs 13-16.<span style="mso-spacerun: yes">  </span>Thus it is not necessary 
    to decide whether the particulars incorporated by reference the material in 
    these tabs. </p>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-weight:bold'>[93]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Having considered the procedural issue, I now propose to consider 
    the substantive issue. The substantive issue is whether the issuance of the 
    first statement of claim on April 2 and the motion for an injunction can serve 
    as the requisite notice pursuant to s. 5(1) for the June 12 statement of claim 
    insofar as the March broadcasts are concerned.<span
style="mso-spacerun: yes">  </span></p>
  <p class=headingNUMBER style='line-height:normal'> <span
style='mso-bidi-font-weight:bold'>[94]<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span></span> Service of the first statement of claim on April 2 cannot constitute 
    notice for the June 12 statement of claim because the April 2 claim does not 
    fulfil the requirement that the notice be given prior to the commencement 
    of litigation.<span style="mso-spacerun: yes">  </span>In addition, by permitting 
    defamation claims that were struck from a previous action for lack of notice 
    to be maintained in a second action, the motions judge’s order undermines 
    the principle established by this Court in <i>Watson</i>,<i> supra</i>,<i> 
    </i>and<i> Weiss</i>,<i> supra</i>,<i> </i>that the failure to deliver notice 
    constitutes an absolute bar to proceeding with these types of defamation claims. 
  </p>
  <p class=headingNUMBER style='line-height:normal'> [95]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Having regard to the particulars furnished respecting the June 12 
    statement of claim the motions judge erred in not striking the claim in regard 
    to the March broadcasts.</p>
  <h4 style='line-height:normal'><span lang=EN-US>The Alleged Defamation in Frank 
    Magazine</span></h4>
  <p class=headingNUMBER style='line-height:normal'> [96]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> Amgen and Karisma take no issue with Janssen’s right to pursue a claim 
    in defamation against Frank Magazine because notice of the claim was given 
    in a timely fashion and prior to the issuance of the June 12 statement of 
    claim.<span style="mso-spacerun: yes">  </span>I would allow this claim to 
    be consolidated with the April 2 action.<span style="mso-spacerun: yes">  
    </span>In view of this, I do not propose to deal with the purported erroneous 
    amendment to the April 2 statement of claim.</p>
  <h4 style='line-height:normal'><span lang=EN-US>CONCLUSION</span></h4>
  <p class=headingNUMBER style='line-height:normal'> [97]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> I would dismiss Janssen’s appeal from the order striking the claim 
    in defamation from the April 2 statement. For the reasons given, I would <span
lang=EN-US style='mso-ansi-language:EN-US'>stay this portion of the judgment for 
    thirty days so that, if Janssen wishes to do so, it may move on proper material 
    before a judge of the Superior Court for leave to amend its pleading to allege 
    defamation and damages respecting certain e&#8209;mails. </span><span
style="mso-spacerun: yes"> </span>I would allow the claim against Frank Magazine 
    in the June 12 statement of claim to stand and I would consolidate that claim 
    with the April 2 action.<span style="mso-spacerun: yes">  </span>I would otherwise 
    allow Amgen and Karisma’s appeal and strike the June 12 statement of claim. 
  </p>
  <h4 style='line-height:normal'><span lang=EN-US>COSTS</span></h4>
  <p class=headingNUMBER style='line-height:normal'> [98]<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
    </span> I would award costs to Amgen fixed in the amount of $11,000 including 
    the motion before the Divisional Court, disbursements, and GST.<span
style="mso-spacerun: yes">  </span>Karisma was allied in interest with Amgen.<span style="mso-spacerun: yes">  
    </span>Its factum adopted the arguments raised by Amgen, as did its brief 
    oral submissions.<span style="mso-spacerun:
yes">  </span>Accordingly, I would award costs to Karisma fixed in the amount 
    of $2,500 all included. </p>
  <h4 style='line-height:normal'><span lang=EN-US>RELEASED: June 7, 2005 (“KMW”)</span></h4>
  <p class=MsoNormal><span lang=EN-US style='mso-ansi-language:
EN-US'>“Karen M. Weiler J.A.”</span></p>
  <p class=MsoNormal><span lang=EN-US style='mso-ansi-language:
EN-US'>“I agree M. Rosenberg J.A.”</span></p>
  <p class=MsoNormal><span lang=EN-US style='mso-ansi-language:
EN-US'>“I agree Susan E. Lang J.A.”</span></p>
</div>
</body>
</html>
